Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas (Q43254768)
Jump to navigation
Jump to search
scientific article published in January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas |
scientific article published in January 2010 |
Statements
1 reference
Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas (English)
1 reference
1 reference
Sabine Nagel
1 reference
Petra Hirschmann
1 reference
Stephan Dirnhofer
1 reference
Ursula Günthert
1 reference
1 January 2010
1 reference
1 reference
38
1 reference
1
1 reference
38-45
1 reference
Identifiers
1 reference
1 reference